Ligand ID: KLN


Drugbank ID:
DB01026
(Ketoconazole)


Indication:
For the treatment of the following systemic fungal infections: candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis.

Get human targets for KLN in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'KLN' AND SARS-RELATED PROTEINS ONLY

1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera throuh AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		1qz8 POLYPROTEIN 1AB
(SARSr-CoV)		5 / 11
PHE B  56
ARG B  10
LEU B 106
ARG B  39
LEU B  42
1.61A12.27
None
SO4  B 695 (-2.6A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		1qz8 POLYPROTEIN 1AB
(SARSr-CoV)		5 / 9
LEU B  88
ILE B  91
ALA B  30
GLY A 104
LEU B   9
1.55A12.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		1wnc E2 GLYCOPROTEIN
(SARSr-CoV)		5 / 9
SER D 924
ILE D1164
ALA F 926
GLY E 928
LEU E 927
1.56A16.35
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		1wnc E2 GLYCOPROTEIN
(SARSr-CoV)		5 / 11
LEU D 930
ILE E1164
THR F 923
GLU F1162
LEU F 927
1.63A16.35
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		1wnc E2 GLYCOPROTEIN
(SARSr-CoV)		5 / 12
ALA A 940
LEU A 941
ALA A 938
GLN B 936
GLN B 939
1.58A14.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		1xak ORF7A ACCESSORY
PROTEIN
(SARSr-CoV)		5 / 11
ILE A  15
PHE A  39
ALA A  40
ARG A  63
LEU A  62
1.58A12.36
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		1xak ORF7A ACCESSORY
PROTEIN
(SARSr-CoV)		5 / 11
ILE A  15
PHE A  39
ALA A  40
ARG A  63
LEU A  62
1.46A12.36
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		1yo4 HYPOTHETICAL PROTEIN
X4
(SARSr-CoV)		5 / 11
LEU A  41
PHE A  48
ALA A  49
THR A  59
GLU A  81
1.69A10.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		1yo4 HYPOTHETICAL PROTEIN
X4
(SARSr-CoV)		5 / 12
SER A  29
LEU A  16
ALA A  49
THR A  59
ARG A  63
1.60A10.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		1z1j 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
PRO B1252
ALA B1267
LEU B1268
ALA B1266
THR B1225
1.55A23.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		1z1j 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
PHE B1219
LEU B1287
ALA B1234
MET B1264
GLU B1270
1.65A22.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		1zv8 E2 GLYCOPROTEIN
(SARSr-CoV)		5 / 12
ALA G  40
LEU G  41
ALA G  38
GLN I  36
GLN I  39
1.48A7.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		1zv8 E2 GLYCOPROTEIN
(SARSr-CoV)		5 / 11
LEU E  20
ILE C  16
THR C  21
GLU A  18
LEU B  19
1.58A8.48
None
None
None
NA  A 209 (-2.3A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		2acf REPLICASE
POLYPROTEIN 1AB
(SARS-COV
Tor2)		4 / 7
ILE B 335
THR B 328
ILE B 205
GLY B 279
1.20A15.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		2ahm REPLICASE
POLYPROTEIN 1AB,
HEAVY CHAIN
(SARSr-CoV)		5 / 12
LEU H 158
ALA H 157
GLN H 163
GLN H 162
ILE H 161
1.45A16.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		2ahm REPLICASE
POLYPROTEIN 1AB,
HEAVY CHAIN
REPLICASE
POLYPROTEIN 1AB,
LIGHT CHAIN
(SARSr-CoV)		5 / 11
SER A  15
ILE A  44
ALA A  53
ARG E 101
LEU E 108
1.58A13.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		2ahm REPLICASE
POLYPROTEIN 1AB,
HEAVY CHAIN
REPLICASE
POLYPROTEIN 1AB,
LIGHT CHAIN
(SARSr-CoV)		5 / 12
LEU F 108
LEU F 103
ILE B  44
ALA B  53
THR B  50
1.43A17.31
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		2ahm REPLICASE
POLYPROTEIN 1AB,
HEAVY CHAIN
REPLICASE
POLYPROTEIN 1AB,
LIGHT CHAIN
(SARSr-CoV)		5 / 11
LEU G 108
ILE C  44
PHE C  54
ALA C  53
THR C  50
1.46A17.31
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		2ahm REPLICASE
POLYPROTEIN 1AB,
HEAVY CHAIN
REPLICASE
POLYPROTEIN 1AB,
LIGHT CHAIN
(SARSr-CoV)		5 / 12
SER B  15
LEU F 108
ILE B  44
ALA B  53
THR B  50
1.56A13.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		2ahm REPLICASE
POLYPROTEIN 1AB,
HEAVY CHAIN
REPLICASE
POLYPROTEIN 1AB,
LIGHT CHAIN
(SARSr-CoV)		5 / 11
LEU A  60
ILE A  44
ALA A  53
ARG E 101
LEU E 108
1.65A13.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		2ajf ACE2
(Homo
sapiens)		5 / 11
LEU B 450
ILE B 446
ALA B 443
GLU B 527
LEU B 585
1.67A21.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		2ajf ACE2
(Homo
sapiens)		5 / 11
LEU B 456
ILE B 513
THR B 519
GLU B 231
LEU B 450
1.61A21.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		2ajf ACE2
(Homo
sapiens)		4 / 5
PHE B 308
SER B 411
PHE B 327
ILE B 544
1.56A21.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		2ajf ACE2
(Homo
sapiens)		5 / 9
LEU A 554
ILE A 407
ALA A 403
GLY A 575
LEU A 570
1.54A21.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		2beq SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
ALA B 940
LEU B 941
ALA B 938
GLN C 936
GLN C 939
1.55A6.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		2bx3 MAIN PROTEINASE
(SARS-COV
Sin2774)		5 / 12
HIS A 172
MET A  17
PRO A 122
ALA A 173
PHE A 112
1.54A23.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		2bx3 MAIN PROTEINASE
(SARS-COV
Sin2774)		5 / 12
LEU A 271
LEU A 272
ALA A 266
THR A 225
GLU A 240
1.52A22.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		2cjr NUCLEOCAPSID PROTEIN
(SARS-COV
TW1)		5 / 12
ALA C 309
ALA D 312
THR C 264
PHE C 275
GLN C 284
1.54A16.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		2cjr NUCLEOCAPSID PROTEIN
(SARS-COV
TW1)		4 / 7
ILE E 321
THR F 283
ILE F 305
GLY F 276
1.02A16.02
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		2cjr NUCLEOCAPSID PROTEIN
(SARS-COV
TW1)		5 / 9
ARG H 320
LEU G 292
ILE G 358
ALA G 360
GLY G 276
1.49A16.02
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		2fav REPLICASE
POLYPROTEIN 1AB
(PP1AB) (ORF1AB)
(SARSr-CoV)		5 / 11
PHE A 133
LEU A  94
PHE A 117
GLU A 105
LEU A 128
1.68A15.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		2fe8 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 11
PHE C 242
PHE C 148
ALA C 140
GLU C 125
LEU C 121
1.63A20.36
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		2fe8 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 9
PHE B 242
LEU B 151
ALA B 140
GLU B 125
LEU B 121
1.58A20.36
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		2g9t ORF1A POLYPROTEIN
(SARSr-CoV)		5 / 12
ARG S  78
SER S  11
LEU O  14
PHE W  19
ALA O  26
1.48A15.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		2ghv SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PHE E 379
LEU C 355
LEU E 374
PHE C 329
ILE C 345
1.35A17.49
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		2ghv SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 7
PHE E 379
LEU E 374
PHE C 329
ILE C 345
1.16A17.49
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		2gib NUCLEOCAPSID PROTEIN
(SARSr-CoV)		4 / 7
ILE B 321
THR A 283
ILE A 305
GLY A 276
1.18A14.32
None
None
None
SO4  A 371 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		2gib NUCLEOCAPSID PROTEIN
(SARSr-CoV)		5 / 9
PHE A 275
LEU A 354
ILE A 338
ALA A 337
GLY B 317
1.66A14.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		2liz 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ALA A 267
LEU A 268
ALA A 266
THR A 225
GLN A 244
1.54A16.24
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		2ozk URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 11
PHE B 213
ILE B 168
ALA B 158
MET B 209
LEU B 298
1.55A20.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		2ozk URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		4 / 7
PHE A 134
ILE A  71
ILE A  69
GLY A 140
1.24A20.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		2ozk URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		4 / 7
PHE A 302
LEU A 331
PHE A 240
ILE A 327
1.19A20.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 11
PHE D 194
LEU D 142
ILE D 186
GLU D 191
LEU D  75
1.51A20.86
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 7
PHE C 213
PHE C 240
SER C 261
LEU C 254
GLY C 253
1.75A20.86
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 9
PHE D 194
LEU D 142
ILE D 186
GLU D 191
LEU D  75
1.67A20.86
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		4 / 7
PHE D 134
ILE D  71
ILE D  69
GLY D 140
1.17A20.86
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		2vj1 MAIN PROTEINASE
(SARSr-CoV)		5 / 12
HIS A 172
MET A  17
PRO A 122
ALA A 173
PHE A 112
1.60A24.18
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		2wct NSP3
(SARSr-CoV)		5 / 11
ARG A 625
SER A 652
LEU A 471
THR A 486
ARG A 628
1.70A20.04
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		3d0g ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
LEU A 240
LEU A 236
THR A 593
ARG A 582
GLU A 527
1.38A21.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		3d0g ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 9
LEU A 558
ILE A 407
ALA A 403
GLY A 575
LEU A 570
1.56A21.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		3d0g ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 11
LEU B 450
ILE B 446
ALA B 443
GLU B 527
LEU B 585
1.68A21.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		3d0g ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 11
SER A 411
LEU A 558
ALA A 550
THR A 548
GLU A 310
1.60A21.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		3d0h ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		4 / 5
PHE A 308
SER A 411
PHE A 327
ILE A 544
1.61A21.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		3d0h ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 10
ASP B 427
SER A 411
ILE A 544
ILE A 407
GLY A 537
1.54A21.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		3e91 3C-LIKE PROTEINASE
(SARSr-CoV)		4 / 5
PHE A 305
PHE A   3
SER A   1
PHE A 294
1.45A22.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		3e9s NSP3
(SARSr-CoV)		5 / 11
PHE A 242
LEU A 151
PHE A 148
ALA A 140
LEU A 121
1.59A20.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		3eaj 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 10
ASP B 245
ILE A 249
LEU B 242
THR B 243
GLY B 109
1.34A22.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		3f9g 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
ILE B 281
ALA B 211
ARG B 222
GLU B 270
LEU B 220
1.67A22.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		3f9g 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 10
ASP A 197
ARG A 131
LEU A 167
THR A 135
GLY B 283
1.48A22.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		3f9g 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
HIS A 172
MET A  17
PRO A 122
ALA A 173
PHE A 112
1.54A22.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		3f9h 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 10
ASP B 197
ARG B 131
LEU B 167
THR B 135
GLY A 283
1.55A21.98
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		3f9h 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
HIS B 172
MET B  17
PRO B 122
ALA B 173
PHE B 112
1.43A22.09
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		3fzd 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
HIS A 172
MET A  17
PRO A 122
ALA A 173
PHE A 112
1.61A23.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		3i6l HLA, A-24
NUCLEOPROTEIN
PEPTIDE
(Homo
sapiens;
SARSr-CoV)		4 / 7
PHE D 109
LEU D 126
ILE F   7
GLY D 112
1.08A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		3i6l HLA, A-24
(Homo
sapiens)		5 / 12
ALA D 136
ALA D 140
THR D 143
MET D  97
GLN D  96
1.41A22.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		3m3v 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
HIS A 172
MET A  17
PRO A 122
ALA A 173
PHE A 112
1.59A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		3sci ACE2
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARSr-CoV)		5 / 9
PHE E 442
SER A  77
ALA A  99
GLU A  35
LEU A  29
1.67A18.28
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		3scj ACE2
(Homo
sapiens)		5 / 11
LEU B 456
ILE B 513
THR B 519
GLU B 231
LEU B 450
1.58A21.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		3scj ACE2
(Homo
sapiens)		4 / 7
PHE A  40
SER A 331
ILE A 358
GLY A 352
1.05A21.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		3sck ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		4 / 5
PHE B 452
PHE B 504
PHE B 512
ILE B 126
1.62A22.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		3sck ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
LEU A 240
LEU A 236
THR A 593
ARG A 582
GLU A 527
1.59A22.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		3scl ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 9
LEU A 554
ILE A 407
ALA A 403
GLY A 575
LEU A 570
1.59A22.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		3scl ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 11
LEU B 456
ILE B 513
THR B 519
GLU B 231
LEU B 450
1.61A22.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		4hi3 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
LEU A 250
LEU A 205
ILE A 259
MET A 276
GLU A 270
1.64A22.20
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		4m0w REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)		6 / 11
PHE A 242
LEU A 151
PHE A 148
ALA A 140
GLU A 125
LEU A 121
1.80A20.48
None
None
None
None
NHE  A 404 (-4.2A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		4m0w UBIQUITIN
(Bos
taurus)		5 / 12
SER B  65
LEU B  43
LEU B  50
ILE B   3
THR B  55
1.55A10.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		4m0w REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)		5 / 12
PHE A  70
SER A 156
PHE A 128
ILE A 152
ALA A 150
1.53A20.48
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		4m0w REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)		5 / 9
SER A 115
ILE A 105
ALA A 108
GLU A 264
GLY A 272
1.63A20.48
 NA  A 402 (-4.4A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		4mm3 PAPAIN-LIKE
PROTEINASE
(SARSr-CoV)		5 / 9
SER B 115
ILE B 105
ALA B 108
GLU B 264
GLY B 272
1.63A20.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		4mm3 PAPAIN-LIKE
PROTEINASE
(SARSr-CoV)		5 / 11
PHE B 242
LEU B 151
PHE B 148
ALA B 140
LEU B 121
1.59A20.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		4rna PAPAIN-LIKE PROTEASE
(Human
betacoronavirus
2c
EMC/2012)		5 / 12
PHE A 269
ARG A 168
LEU A 104
ILE A 152
THR A 119
1.61A22.31
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		4tww 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
HIS B 172
MET B  17
PRO B 122
ALA B 173
PHE B 112
1.61A23.45
3A7  B 401 ( 4.7A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		5c8t GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
HIS B 314
LEU B 322
ALA B 320
PHE B 445
ILE B 474
1.50A21.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		5e6j POLYUBIQUITIN-B
(synthetic
construct)		5 / 12
LEU C  43
LEU C  50
ILE C   3
THR C  55
GLU F  64
1.46A10.24
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		5e6j POLYUBIQUITIN-B
REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV;
synthetic
construct)		5 / 11
SER F  65
LEU F  43
ILE F  61
ALA F  46
GLU A  68
1.65A10.24
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		5e6j REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 9
SER D 115
ILE D 105
ALA D 108
GLU D 264
GLY D 272
1.60A20.48
None
None
None
None
AYE  E  76 ( 4.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		5e6j POLYUBIQUITIN-B
REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV;
synthetic
construct)		5 / 9
SER F  65
LEU F  43
ILE F  61
ALA F  46
GLU A  68
1.50A10.24
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		5e6j REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 12
PHE D  70
SER D 156
PHE D 128
ILE D 152
ALA D 150
1.51A20.48
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		5e6j POLYUBIQUITIN-B
REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV;
synthetic
construct)		5 / 11
SER F  65
LEU F  43
ILE F  61
ALA F  46
GLU A  68
1.57A10.24
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		5e6j REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 11
PHE D 242
LEU D 151
PHE D 148
ALA D 140
LEU D 121
1.65A20.48
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		5f22 NSP8
NSP7
(SARSr-CoV)		5 / 11
LEU B 108
ILE A  44
PHE A  54
ALA A  53
THR A  50
1.51A14.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		5f22 NSP8
NSP7
(SARSr-CoV)		5 / 12
LEU B 108
LEU B 103
ILE A  44
ALA A  53
THR A  50
1.48A14.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 11
ARG D  53
SER D  28
LEU O  14
PHE D   8
ARG D  52
1.57A23.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 11
ARG D  53
SER D  28
LEU O  14
PHE D   8
ARG D  52
1.53A23.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 12
LEU A 157
ALA A 119
MET A 169
GLN A 168
ILE A 164
1.41A21.52
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		5tl6 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 11
PHE B 242
LEU B 151
PHE B 148
ALA B 140
LEU B 121
1.60A20.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		5tl6 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 9
SER B 115
ILE B 105
ALA B 108
GLU B 264
GLY B 272
1.65A20.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		5tl6 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 12
PHE D  70
SER D 156
PHE D 128
ILE D 152
ALA D 150
1.60A20.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		5tl7 UBIQUITIN-LIKE
PROTEIN ISG15
(Mus
musculus)		5 / 12
PHE C 124
LEU C  80
THR C 104
MET C 129
GLU C 137
1.65A10.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		5wrg SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 7
SER A 919
THR A 809
ILE A 916
GLY A 928
1.09A17.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		5wrg SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 7
PHE A 529
LEU A 538
ILE A 570
GLY A 536
1.12A17.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		5x29 ENVELOPE SMALL
MEMBRANE PROTEIN
(SARSr-CoV)		5 / 11
ARG E  38
LEU D  31
ILE D  46
ALA D  44
LEU D  39
1.66A11.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		5x29 ENVELOPE SMALL
MEMBRANE PROTEIN
(SARSr-CoV)		4 / 5
PHE D  23
PHE C  26
PHE E  26
ILE C  33
1.62A11.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		5x4r S PROTEIN
(MERS-CoV)		4 / 7
PHE A 164
PHE A 116
LEU A 171
PHE A 254
1.13A21.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		5x58 SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		4 / 7
PHE B 379
SER B 386
LEU B 355
PHE B 361
1.11A17.80
None
None
NAG  B1307 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		5x58 SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 11
PHE A 909
ILE C 687
PHE A 870
ALA A 875
MET A 884
1.55A17.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		5x59 S PROTEIN
(MERS-CoV)		5 / 9
ARG C 614
ILE A1054
ALA A1049
GLY C 640
LEU C 638
1.59A16.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 10
ASP A 850
ARG A 797
ILE A 800
PHE A 764
LEU C 681
1.23A17.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		4 / 5
PHE A  83
SER A 105
PHE A  89
ILE A 226
1.55A17.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 12
PRO A1072
LEU B 876
ALA B 866
THR B 865
GLN B 895
1.46A15.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 12
SER C 914
LEU C 803
PHE C 799
ILE C 913
THR C 706
1.55A17.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 11
PHE A 168
ALA A 167
THR A 121
ARG A 126
GLU A 162
1.63A17.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		4 / 7
PHE C 325
PHE C 360
ILE C 428
GLY C 326
1.13A17.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		5x5c S PROTEIN
(MERS-CoV)		5 / 12
LEU B1098
ALA B1099
PHE B1136
MET B1137
GLN B 792
1.57A14.38
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		5x5c S PROTEIN
(MERS-CoV)		5 / 12
LEU B 443
LEU B 441
PHE B 385
ILE B 480
THR B 477
1.36A16.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		5x5c S PROTEIN
(MERS-CoV)		4 / 5
PHE C1012
PHE C1126
SER C 949
ILE C 861
1.35A16.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		5x5f S PROTEIN
(MERS-CoV)		5 / 11
LEU C 414
ILE C 480
PHE C 418
ALA C 482
THR C 483
1.52A16.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		5x5f S PROTEIN
(MERS-CoV)		4 / 7
PHE B 164
PHE B 116
LEU B 171
PHE B 254
1.13A16.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		5xlr SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 5
PHE C 700
PHE C 782
PHE C 888
ILE A1112
1.54A17.55
PHE  C 700 ( 1.3A)
PHE  C 782 ( 1.3A)
PHE  C 888 ( 1.3A)
ILE  A1112 ( 0.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		5xlr SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 10
SER A 798
PHE A 764
LEU A 846
ILE A 787
GLY A1041
1.48A17.55
SER  A 798 ( 0.0A)
PHE  A 764 ( 1.3A)
LEU  A 846 ( 0.6A)
ILE  A 787 ( 0.7A)
GLY  A1041 ( 0.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		5xlr SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 9
SER A 798
LEU A1045
ALA A1037
GLY A 862
LEU A 859
1.67A17.55
SER  A 798 ( 0.0A)
LEU  A1045 ( 0.6A)
ALA  A1037 ( 0.0A)
GLY  A 862 ( 0.0A)
LEU  A 859 ( 0.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		5y3q REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)		5 / 11
PHE A 242
LEU A 151
PHE A 148
ALA A 140
LEU A 121
1.65A20.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		5zvm SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
SER A 956
LEU B 948
PHE C 952
ILE B 955
ALA B 954
1.46A11.78
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		6acc SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 10
ASP A 850
ARG A 797
ILE A 800
PHE A 764
LEU B 681
1.44A17.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		6acg ACE2
(Homo
sapiens)		4 / 5
PHE D 308
SER D 411
PHE D 327
ILE D 544
1.52A21.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 9
PHE C 629
SER C 582
LEU B 846
ILE C 299
ALA C 658
1.33A17.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PHE C 629
SER C 582
LEU B 846
ILE C 299
ALA C 658
1.28A17.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		6acg ACE2
(Homo
sapiens)		5 / 12
LEU D 240
LEU D 236
THR D 593
ARG D 582
GLU D 527
1.61A21.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 7
ILE B 152
THR B 160
ILE B 234
GLY B 104
0.95A17.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
ALA B1038
ALA B1037
THR B 856
GLN B 786
ILE B 787
1.32A15.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 11
PHE C 629
SER C 582
LEU B 846
ILE C 299
ALA C 658
1.34A17.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6acj SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 7
SER A1003
LEU A 930
ILE A1000
GLY A 928
0.97A17.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		6acj SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 5
PHE B 870
PHE B 784
SER B 798
ILE B 800
1.44A17.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6ack ACE2
(Homo
sapiens)		5 / 9
LEU D 558
ILE D 407
ALA D 403
GLY D 575
LEU D 570
1.46A21.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		6ack ACE2
(Homo
sapiens)		5 / 10
PHE D 523
PHE D 438
LEU D 444
THR D 445
ILE D 421
1.61A21.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 11
SER A 785
LEU A1045
ILE A 913
THR A 921
LEU A 803
1.42A17.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		4 / 5
PHE A 213
SER A 292
PHE A  62
ILE A 295
1.57A18.16
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 11
PHE C 909
ILE B 687
PHE C 870
ALA C 875
MET C 884
1.73A18.16
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 10
ASP A 850
ARG A 797
ILE A 800
PHE A 764
LEU C 681
1.31A18.16
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
ALA A1038
ALA A1037
THR A 856
GLN A 786
ILE A 787
1.54A16.02
None
None
None
NAG  A1305 (-4.0A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		6crw SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		4 / 7
PHE A  89
ILE A  87
THR A  92
GLY A  77
1.12A17.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		6crx SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 10
ASP A 850
ARG A 797
ILE A 800
PHE A 764
LEU C 681
1.26A17.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		6crx SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 11
PHE A 360
LEU A 322
ILE A 345
ALA A 350
LEU A 355
1.68A17.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		6crz SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
PHE A 179
SER A 239
LEU A 235
PHE A  76
ALA A 139
1.41A17.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		6cs1 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
PRO B1072
LEU C 876
ALA C 866
THR C 865
MET C 884
1.27A15.90
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		6cs1 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 11
SER A1012
PHE C1024
ARG A1001
GLU A 762
LEU C1006
1.52A17.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6cs1 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		4 / 7
PHE B 529
LEU B 538
ILE B 570
GLY B 536
1.09A17.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		6cs2 ACE2
(Homo
sapiens)		4 / 5
PHE D 308
SER D 411
PHE D 327
ILE D 544
1.63A20.92
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		6cs2 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		4 / 5
PHE B 213
SER B 292
PHE B  62
ILE B 295
1.29A17.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		6cs2 ACE2
(Homo
sapiens)		5 / 12
PHE D 327
ARG D 306
LEU D 370
ILE D 421
MET D 323
1.65A20.92
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6cs2 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 9
SER A 798
LEU A1045
ALA A1037
GLY A 862
LEU A 859
1.38A17.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		6jyt HELICASE
(SARSr-CoV)		5 / 12
PRO B 514
ALA B 454
PHE B 587
GLN B 548
ILE B 565
1.56A21.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		6jyt HELICASE
(SARSr-CoV)		5 / 11
LEU B 438
ILE B 399
PHE B 291
ALA B 292
MET B 274
1.66A25.04
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		6jyt HELICASE
(SARSr-CoV)		5 / 11
LEU A 252
ILE A 370
ALA A 368
THR A 367
GLU A 244
1.62A25.04
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		6jyt HELICASE
(SARSr-CoV)		5 / 12
PHE A 343
ILE A 370
ALA A 368
THR A 366
ARG A 332
1.48A25.04
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		6jyt HELICASE
(SARSr-CoV)		5 / 10
ASP A  59
LEU A  83
THR A  61
ILE A 109
GLY A  17
1.54A25.04
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		6lzg ACE2
(Homo
sapiens)		5 / 12
PHE A 438
LEU A 423
LEU A 418
ILE A 307
ALA A 311
1.61A21.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		6m18 ACE2
(Homo
sapiens)		4 / 7
PHE B  40
SER B 331
ILE B 358
GLY B 352
0.97A19.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6m18 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		5 / 9
SER C 118
ILE C 497
ALA C 498
GLU C 437
GLY C  93
1.40A22.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		6m1d SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		4 / 5
PHE C 400
PHE C 473
SER C 477
ILE C 187
1.26A22.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		6m1d ACE2
(Homo
sapiens)		5 / 12
LEU B 423
LEU B 418
ILE B 307
ALA B 311
GLU B 406
1.43A19.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6m1d SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		4 / 7
PHE A 473
PHE A 123
ILE A 462
GLY A 470
1.19A22.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6m1d ACE2
(Homo
sapiens)		4 / 7
SER D 707
PHE D 683
ILE D 711
GLY D 726
1.12A19.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		6m1d ACE2
(Homo
sapiens)		5 / 11
LEU B 585
ILE B 233
THR B 519
GLU B 224
LEU B 520
1.58A19.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6m1d ACE2
(Homo
sapiens)		5 / 9
LEU D 554
ILE D 407
ALA D 403
GLY D 575
LEU D 570
1.55A19.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		6nb6 SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 10
ASP C 850
ARG C 797
ILE C 800
PHE C 764
LEU A 681
1.29A17.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		6nb7 SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 7
PHE B1034
ILE B 704
ILE B 702
GLY B1017
1.22A17.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		6nb7 SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PRO B1072
LEU A 876
ALA A 866
THR A 865
GLN A 895
1.43A15.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		6nur NSP12
NSP7
(SARSr)		4 / 7
PHE A 415
SER C  10
ILE C  39
GLY A 839
1.41A20.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6nur NSP7
NSP8
(SARSr-CoV)		5 / 9
SER C  10
LEU D 122
ILE C  39
ALA C  48
LEU D 103
1.65A12.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		6nur NSP12
(SARSr-CoV)		5 / 11
LEU A 883
ILE A 837
ALA A 866
GLU A 857
LEU A 908
1.56A20.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		6nur NSP12
(SARSr-CoV)		5 / 11
LEU A 883
ILE A 837
ALA A 866
GLU A 857
LEU A 908
1.52A20.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		6nur NSP12
NSP7
NSP8
(SARSr-CoV)		5 / 11
LEU D  98
ILE C  39
PHE C  49
THR C  46
GLU A 436
1.64A17.03
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6nur NSP12
(SARSr-CoV)		6 / 9
ARG A 858
LEU A 883
ILE A 837
ALA A 866
GLU A 857
LEU A 908
1.78A20.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		6nur NSP7
NSP8
(SARSr-CoV)		5 / 11
SER C  10
ILE C  39
ALA C  48
ARG D  96
LEU D 103
1.46A12.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		6nur NSP12
(SARSr-CoV)		5 / 7
PHE A 429
PHE A 859
ILE A 888
ILE A 864
GLY A 839
1.66A20.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		6nur NSP12
NSP8
(SARSr-CoV)		5 / 11
LEU B  98
ILE B 120
ALA B 125
MET A 668
LEU A 401
1.72A17.03
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6nur NSP12
NSP7
(SARSr-CoV)		5 / 7
PHE A 415
SER C  10
LEU A 437
ILE C  39
GLY A 839
1.50A20.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		6nus NSP12
(SARSr-CoV)		5 / 12
ARG A 583
LEU A 638
LEU A 575
PHE A 480
ILE A 589
1.58A20.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		6vw1 ACE2
(Homo
sapiens)		4 / 7
PHE A  40
SER A 331
ILE A 358
GLY A 352
0.98A21.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		5 / 9
LEU H  80
ILE H  51
ALA H  78
GLY H 104
LEU H   4
1.74A17.71
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		4 / 7
PHE L  71
SER L  25
LEU L  27
ILE L   2
1.33A15.53
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		4 / 7
LEU H   4
PHE H  29
ILE H  51
GLY H 104
1.46A17.71
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		4 / 7
PHE H 146
SER H   7
ILE H  20
THR H  87
1.73A17.71
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		5 / 11
SER L 127
LEU H 175
THR L 178
GLU L 123
LEU H 141
1.65A15.53
None
None
GOL  L 301 (-3.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		6yla HEAVY CHAIN
(Homo
sapiens)		4 / 7
SER H  75
ILE H  76
THR B 155
GLY B 161
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 9
LEU H  81
ILE H  51
ALA H  79
GLY H 110
LEU H   4
1.67A20.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6yla LIGHT CHAIN
(Homo
sapiens)		4 / 7
PHE C  77
SER C  25
LEU C  30
ILE C   2
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		4 / 7
SER H  75
ILE H  76
THR C 170
GLY B 166
1.21A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		4 / 7
SER C 214
ILE C 123
THR B 187
GLY B 137
1.57A
MLI  C 304 (-2.5A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 9
LEU B  81
ILE B  51
ALA B  79
GLY B 110
LEU B   4
1.69A20.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6yla HEAVY CHAIN
(Homo
sapiens)		4 / 7
LEU B   4
PHE B  29
ILE B  51
GLY B 110
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		6yla HEAVY CHAIN
(Homo
sapiens)		4 / 7
SER H  75
ILE H  76
THR B 169
GLY B 166
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6yla LIGHT CHAIN
(Homo
sapiens)		4 / 7
SER C  26
LEU C  39
ILE C   2
GLY C  72
1.26A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6yla LIGHT CHAIN
(Homo
sapiens)		4 / 7
SER L  26
LEU L  39
ILE L   2
GLY L  72
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6yla HEAVY CHAIN
(Homo
sapiens)		4 / 7
LEU H   4
PHE H  29
ILE H  51
GLY H 110
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6ym0 LIGHT CHAIN
(Homo
sapiens)		4 / 7
SER L  26
LEU L  39
ILE L   2
GLY L  72
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6ym0 HEAVY CHAIN
(Homo
sapiens)		5 / 9
LEU H  81
ILE H  51
ALA H  72
GLY H 110
LEU H   4
1.68A20.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6ym0 HEAVY CHAIN
(Homo
sapiens)		5 / 9
LEU H  81
ILE H  51
ALA H  79
GLY H 110
LEU H   4
1.76A20.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6ym0 HEAVY CHAIN
(Homo
sapiens)		4 / 7
LEU H   4
PHE H  29
ILE H  51
GLY H 110
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6yor IGG L CHAIN
(Homo
sapiens)		4 / 7
SER C  26
LEU C  39
ILE C   2
GLY C  72
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6yor IGG H CHAIN
(Homo
sapiens)		5 / 9
LEU H  81
ILE H  51
ALA H  79
GLY H 110
LEU H   4
1.66A20.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6yor IGG H CHAIN
(Homo
sapiens)		4 / 7
LEU H   4
PHE H  29
ILE H  51
GLY H 110
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6yor IGG H CHAIN
(Homo
sapiens)		4 / 7
LEU B   4
PHE B  29
ILE B  51
GLY B 110
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		6yor IGG L CHAIN
(Homo
sapiens)		4 / 7
SER L  26
LEU L  39
ILE L   2
GLY L  72
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6yor IGG H CHAIN
(Homo
sapiens)		5 / 9
LEU B  81
ILE B  51
ALA B  79
GLY B 110
LEU B   4
1.67A20.58
None